December 9, 2009
Mayo Clinic linked biotech plans estimated $74M IPO
A Belgium biotech company that licenses Mayo Clinic research and is partially owned by Mayo – Cardio3 BioSciences Cardio3 BioSciences is licensing Mayo Clinic research about “differentiating” stem cells, or turning generic stem cells from bone marrow into cardiac cells. Post-Bulletin, by Jeff Kiger, 12/8/09
Tags: biotech, Cardio3 BioSciences